BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 17398018)

  • 41. Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: a comparison with threshold-based approaches, CT and surgical specimens.
    Wanet M; Lee JA; Weynand B; De Bast M; Poncelet A; Lacroix V; Coche E; Grégoire V; Geets X
    Radiother Oncol; 2011 Jan; 98(1):117-25. PubMed ID: 21074882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of CT and positron emission tomography/CT coregistered images in planning radical radiotherapy in patients with non-small-cell lung cancer.
    Macmanus M; D'Costa I; Everitt S; Andrews J; Ackerly T; Binns D; Lau E; Ball D; Weih L; Hicks RJ
    Australas Radiol; 2007 Aug; 51(4):386-93. PubMed ID: 17635480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phantom study on three-dimensional target volume delineation by PET/CT-based auto-contouring.
    Zhang T; Tachiya Y; Sakaguchi Y; Mitsumoto K; Mitsumoto T; Ohya N; Sasaki M
    Fukuoka Igaku Zasshi; 2010 Nov; 101(11):238-46. PubMed ID: 21391442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases.
    Bundschuh RA; Andratschke N; Dinges J; Duma MN; Astner ST; Brügel M; Ziegler SI; Molls M; Schwaiger M; Essler M
    Strahlenther Onkol; 2012 Jul; 188(7):592-8. PubMed ID: 22441441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer.
    Sato M; Okumura T; Kaito K; Kiyoshima M; Asato Y; Uchiumi K; Iijima H; Hashimoto I; Kaburagi T; Amemiya R
    Ann Nucl Med; 2009 Jan; 23(1):49-57. PubMed ID: 19205838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inter and intraobserver variation in gross tumor delineation on megavoltage CT images in patients undergoing tomotherapy-based image-guided radiotherapy for postoperative vault recurrences.
    Upasani M; Chopra S; Engineer R; Medhi S; Master Z; Mahantshetty U; Shrivastava SK
    J Cancer Res Ther; 2011; 7(3):292-7. PubMed ID: 22044810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of FDG-PET/CT fused imaging on tumor volume assessment of head-and-neck squamous cell carcinoma: intermethod and interobserver variations.
    Murakami R; Uozumi H; Hirai T; Nishimura R; Katsuragawa S; Shiraishi S; Toya R; Tashiro K; Kawanaka K; Oya N; Tomiguchi S; Yamashita Y
    Acta Radiol; 2008 Jul; 49(6):693-9. PubMed ID: 18568563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [F18] FDG-PET/CT for manual or semiautomated GTV delineation of the primary tumor for radiation therapy planning in patients with esophageal cancer: is it useful?
    Walter F; Jell C; Zollner B; Andrae C; Gerum S; Ilhan H; Belka C; Niyazi M; Roeder F
    Strahlenther Onkol; 2021 Sep; 197(9):780-790. PubMed ID: 33104815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does partial volume corrected maximum SUV based on count recovery coefficient in 3D-PET/CT correlate with clinical aggressiveness of non-Hodgkin's lymphoma?
    Tsujikawa T; Otsuka H; Morita N; Saegusa H; Kobayashi M; Okazawa H; Nishitani H
    Ann Nucl Med; 2008 Jan; 22(1):23-30. PubMed ID: 18250984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma.
    Bird D; Scarsbrook AF; Sykes J; Ramasamy S; Subesinghe M; Carey B; Wilson DJ; Roberts N; McDermott G; Karakaya E; Bayman E; Sen M; Speight R; Prestwich RJ
    BMC Cancer; 2015 Nov; 15():844. PubMed ID: 26530182
    [TBL] [Abstract][Full Text] [Related]  

  • 51. (18)F-FDG PET-CT simulation for non-small-cell lung cancer: effect in patients already staged by PET-CT.
    Hanna GG; McAleese J; Carson KJ; Stewart DP; Cosgrove VP; Eakin RL; Zatari A; Lynch T; Jarritt PH; Young VA; O'Sullivan JM; Hounsell AR
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):24-30. PubMed ID: 19665324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system.
    Barker JL; Garden AS; Ang KK; O'Daniel JC; Wang H; Court LE; Morrison WH; Rosenthal DI; Chao KS; Tucker SL; Mohan R; Dong L
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):960-70. PubMed ID: 15234029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion.
    Riegel AC; Berson AM; Destian S; Ng T; Tena LB; Mitnick RJ; Wong PS
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):726-32. PubMed ID: 16626888
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
    Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
    J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.
    Schinagl DA; Vogel WV; Hoffmann AL; van Dalen JA; Oyen WJ; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1282-9. PubMed ID: 17967318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC).
    Greco C; Rosenzweig K; Cascini GL; Tamburrini O
    Lung Cancer; 2007 Aug; 57(2):125-34. PubMed ID: 17478008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Target delineation in post-operative radiotherapy of brain gliomas: interobserver variability and impact of image registration of MR(pre-operative) images on treatment planning CT scans.
    Cattaneo GM; Reni M; Rizzo G; Castellone P; Ceresoli GL; Cozzarini C; Ferreri AJ; Passoni P; Calandrino R
    Radiother Oncol; 2005 May; 75(2):217-23. PubMed ID: 15885831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variability of gross tumour volume delineation: MRI and CT based tumour and lymph node delineation for lung radiotherapy.
    Kumar S; Holloway L; Boxer M; Yap ML; Chlap P; Moses D; Vinod S
    Radiother Oncol; 2022 Feb; 167():292-299. PubMed ID: 34896156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PET CT thresholds for radiotherapy target definition in non-small-cell lung cancer: how close are we to the pathologic findings?
    Wu K; Ung YC; Hornby J; Freeman M; Hwang D; Tsao MS; Dahele M; Darling G; Maziak DE; Tirona R; Mah K; Wong CS
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):699-706. PubMed ID: 19836163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Explicit incorporation of prior anatomical information into a nonrigid registration of thoracic and abdominal CT and 18-FDG whole-body emission PET images.
    Camara O; Delso G; Colliot O; Moreno-Ingelmo A; Bloch I
    IEEE Trans Med Imaging; 2007 Feb; 26(2):164-78. PubMed ID: 17304731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.